Early-Stage trial tests new drug formulation in healthy volunteers
Knowledge-focused
Completed
This early-stage study aims to understand how the body absorbs two different capsule versions of an investigational drug called TP-3654, which is being developed for a bone marrow cancer called myelofibrosis. It involves 24 healthy adult volunteers and will test how taking the ca…
Phase: PHASE1 • Sponsor: Sumitomo Pharma America, Inc. • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC